Literature DB >> 16021278

Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors.

Alexandre Wagner Silva de Souza1, Francisca Satomi Hatta, Fausto Miranda, Emília Inoue Sato.   

Abstract

CONTEXT AND
OBJECTIVE: Atherosclerotic disease is an important cause of morbidity and mortality in systemic lupus erythematosus (SLE) patients. No previous study has estimated carotid disease prevalence in such patients in Brazil. The aim was to evaluate the prevalence of atherosclerotic plaque in carotid arteries, in SLE patients and controls, and to verify possible associations between risk factors and carotid plaque. DESIGN AND
SETTING: Cross-sectional study, at Universidade Federal de São Paulo--Escola Paulista de Medicina.
METHODS: Carotid plaque prevalence was assessed by B-mode ultrasound in 82 female SLE patients of mean age 34.0 years and 62 controls of mean age 35.7 years. Plaque was defined as a distinct area of hyperechogenicity and/or focal protrusion of the vessel wall into the lumen. Risk factors for coronary disease and SLE-related variables were determined.
RESULTS: 50% of patients and 29% of controls presented carotid plaque. Older age, longer disease duration, higher Systemic Lupus International Collaborating Clinics (SLICC) score, higher levels of low-density lipoprotein and greater diabetes, obesity, premature ovarian failure and family history of coronary artery disease were found in patients with carotid plaque than in those without plaque. Patients with plaque were younger than controls with plaque. SLE diagnosis, obesity, older age, higher SLICC score and longer disease duration were independent risk factors for carotid plaque.
CONCLUSION: Young patients with SLE present higher prevalence of carotid plaque than controls. SLE diagnosis was a significant risk factor for carotid atherosclerosis.

Entities:  

Mesh:

Year:  2005        PMID: 16021278     DOI: 10.1590/s1516-31802005000300010

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  8 in total

Review 1.  The role of antimalarial agents in the treatment of SLE and lupus nephritis.

Authors:  Senq-J Lee; Earl Silverman; Joanne M Bargman
Journal:  Nat Rev Nephrol       Date:  2011-10-18       Impact factor: 28.314

2.  Metabolic syndrome in systemic lupus erythematosus: lower prevalence in Brazil than in the USA.

Authors:  George D Azevedo; Rafael G N Gadelha; Maria José Vilar
Journal:  Ann Rheum Dis       Date:  2007-11       Impact factor: 19.103

Review 3.  Is Obesity a Risk Factor for Carotid Atherosclerotic Disease?-Opportunistic Review.

Authors:  Joana Ferreira; Pedro Cunha; Alexandre Carneiro; Isabel Vila; Cristina Cunha; Cristina Silva; Adhemar Longatto-Filho; Amílcar Mesquita; Jorge Cotter; Margarida Correia-Neves; Armando Mansilha
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-17

4.  Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus.

Authors:  Parasar Ghosh; Amresh Kumar; Sudeep Kumar; Amita Aggarwal; Nakul Sinha; Ramnath Misra
Journal:  Clin Rheumatol       Date:  2009-07-19       Impact factor: 2.980

5.  Cardiovascular complications of systemic lupus erythematosus: impact of risk factors and therapeutic efficacy-a tertiary centre experience in an Appalachian state.

Authors:  Elise Danielle McVeigh; Amna Batool; Arnold Stromberg; Ahmed Abdel-Latif; Nayef Mohammed Kazzaz
Journal:  Lupus Sci Med       Date:  2021-05

6.  Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Fibroblast Growth Factor 23- Phosphate Axis.

Authors:  Yaser Ammar; Amira Mohamed; Gihane Khalil; Dalia Maharem
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-08-27

7.  Cardiovascular disease in latin american patients with systemic lupus erythematosus: a cross-sectional study and a systematic review.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Julián Caro-Moreno; Nicolás Molano-González; Rubén D Mantilla; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Autoimmune Dis       Date:  2013-11-03

Review 8.  Cardiovascular involvement in autoimmune diseases.

Authors:  Jenny Amaya-Amaya; Laura Montoya-Sánchez; Adriana Rojas-Villarraga
Journal:  Biomed Res Int       Date:  2014-07-22       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.